




Searching News Database: Personalized Medicine
HSMN NewsFeed - 25 Jul 2024
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
HSMN NewsFeed - 14 Feb 2024
Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead
Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead
HSMN NewsFeed - 3 Feb 2023
Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer
Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer
HSMN NewsFeed - 2 Feb 2023
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
HSMN NewsFeed - 26 Aug 2020
MedGenome announces Strategic Collaboration in Parkinson's Disease with Denali Therapeutics
MedGenome announces Strategic Collaboration in Parkinson's Disease with Denali Therapeutics
HSMN NewsFeed - 24 Aug 2020
Leap Therapeutics Expands Leadership Team with Addition of Two Industry Veterans
Leap Therapeutics Expands Leadership Team with Addition of Two Industry Veterans
HSMN NewsFeed - 15 Apr 2020
Indivumed Launches Global Oncology Alliance For Personalized Medicine ("Onco AI-Med")
Indivumed Launches Global Oncology Alliance For Personalized Medicine ("Onco AI-Med")
HSMN NewsFeed - 29 Jul 2019
RenalytixAI Appoints Thomas McLain as President and Chief Commercial Officer
RenalytixAI Appoints Thomas McLain as President and Chief Commercial Officer
HSMN NewsFeed - 3 Jul 2019
Caris Life Sciences Appoints Steven D. Averbuch, M.D., to Its Scientific Advisory Board
Caris Life Sciences Appoints Steven D. Averbuch, M.D., to Its Scientific Advisory Board
HSMN NewsFeed - 13 Jun 2019
Elekta Increases Focus on Digitization - Hires Sukhveer Singh to Drive Elekta Digital strategy
Elekta Increases Focus on Digitization - Hires Sukhveer Singh to Drive Elekta Digital strategy
HSMN NewsFeed - 7 Feb 2019
Onkos Surgical(R) Announces the Release of MyTray(TM) a Breakthrough in Personalized Surgical Planning
Onkos Surgical(R) Announces the Release of MyTray(TM) a Breakthrough in Personalized Surgical Planning
HSMN NewsFeed - 31 Jan 2019
IGM Biosciences Appoints M. Kathleen Behrens, Ph.D., to Board of Directors
IGM Biosciences Appoints M. Kathleen Behrens, Ph.D., to Board of Directors
HSMN NewsFeed - 30 Jan 2019
ArcherDX Acquires Baby Genes, a Genetics-Based Personalized Medicine Company
ArcherDX Acquires Baby Genes, a Genetics-Based Personalized Medicine Company
HSMN NewsFeed - 4 Jan 2019
SOPHiA GENETICS Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine
SOPHiA GENETICS Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine
HSMN NewsFeed - 18 Oct 2018
PolarityTE(R) Announces Former Acelity Leader Sharon Whalen as Vice President of Market Access
PolarityTE(R) Announces Former Acelity Leader Sharon Whalen as Vice President of Market Access
HSMN NewsFeed - 16 Oct 2018
Precision For Medicine Acquires Liquid Biopsy And Tissue Profiling Pioneer ApoCell
Precision For Medicine Acquires Liquid Biopsy And Tissue Profiling Pioneer ApoCell
HSMN NewsFeed - 18 Sep 2018
Agendia and Genecast Biotechnology Partner to Launch MammaPrint(R) and BluePrint(R) in China
Agendia and Genecast Biotechnology Partner to Launch MammaPrint(R) and BluePrint(R) in China
HSMN NewsFeed - 5 Sep 2018
ArcherDX, Inc. Names Former Foundation Medicine Executive Steven Kafka, Ph.D. to its Board of Directors
ArcherDX, Inc. Names Former Foundation Medicine Executive Steven Kafka, Ph.D. to its Board of Directors
HSMN NewsFeed - 10 May 2018
Interpace Diagnostics Announces Expanded Coverage Among Blue Cross Blue Shield Plans
Interpace Diagnostics Announces Expanded Coverage Among Blue Cross Blue Shield Plans
HSMN NewsFeed - 13 Mar 2018
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC
HSMN NewsFeed - 9 Jan 2018
Syapse Enters Strategic Collaboration with Roche to Advance Precision Medicine in Oncology
Syapse Enters Strategic Collaboration with Roche to Advance Precision Medicine in Oncology
HSMN NewsFeed - 19 Dec 2017
Agendia and Bluebee Partner to Bring New NGS-based MammaPrint(R) BluePrint(R) Breast Cancer Kit to Market
Agendia and Bluebee Partner to Bring New NGS-based MammaPrint(R) BluePrint(R) Breast Cancer Kit to Market
HSMN NewsFeed - 4 Dec 2017
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
HSMN NewsFeed - 18 Aug 2017
EndoPredict(R) Receives Positive Coverage Decisions From Medicare and Anthem
EndoPredict(R) Receives Positive Coverage Decisions From Medicare and Anthem
HSMN NewsFeed - 17 May 2017
Caris Life Sciences Appoints John Marshall, M.D., as Chief Medical Officer
Caris Life Sciences Appoints John Marshall, M.D., as Chief Medical Officer
HSMN NewsFeed - 28 Mar 2017
Introducing PROMETHEUS(R) IBcause(TM): Convenient All-in-One Diagnostic Test for Persistent Diarrhea
Introducing PROMETHEUS(R) IBcause(TM): Convenient All-in-One Diagnostic Test for Persistent Diarrhea
HSMN NewsFeed - 13 Mar 2017
Myriad Genetics Launches the EndoPredict(R) Test in the United States for Patients with Breast Cancer
Myriad Genetics Launches the EndoPredict(R) Test in the United States for Patients with Breast Cancer
HSMN NewsFeed - 22 Feb 2017
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
HSMN NewsFeed - 25 Jan 2017
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
HSMN NewsFeed - 17 Jan 2017
Personal Genome Diagnostics Adds James Lewis as Senior Vice President of Corporate Development
Personal Genome Diagnostics Adds James Lewis as Senior Vice President of Corporate Development
HSMN NewsFeed - 6 Oct 2016
Interpace Diagnostics Launches New Streamlined Molecular Product for Pancreatic Cysts
Interpace Diagnostics Launches New Streamlined Molecular Product for Pancreatic Cysts
HSMN NewsFeed - 22 Aug 2016
Singlera Genomics Raises $20 Million In Series A Financing Led by Lilly Asia Ventures
Singlera Genomics Raises $20 Million In Series A Financing Led by Lilly Asia Ventures
HSMN NewsFeed - 26 Jul 2016
Inivata Adds to Board of Directors With Appointment of Peter Wrighton-Smith
Inivata Adds to Board of Directors With Appointment of Peter Wrighton-Smith
HSMN NewsFeed - 23 May 2016
Interpace Diagnostics Presents New Clinical Utility Data at Digestive Disease Week
Interpace Diagnostics Presents New Clinical Utility Data at Digestive Disease Week
HSMN NewsFeed - 16 May 2016
Luminex Corporation Signs Definitive Agreement to Acquire Nanosphere, Inc.
Luminex Corporation Signs Definitive Agreement to Acquire Nanosphere, Inc.
HSMN NewsFeed - 9 May 2016
Personal Genome Diagnostics Names Industry Veteran Douglas Ward as Chief Executive Officer
Personal Genome Diagnostics Names Industry Veteran Douglas Ward as Chief Executive Officer
HSMN NewsFeed - 18 Apr 2016
Interpace Diagnostics Announces New Coding by Novitas Solutions for PancraGen(TM)
Interpace Diagnostics Announces New Coding by Novitas Solutions for PancraGen(TM)
HSMN NewsFeed - 7 Mar 2016
Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health
Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health
HSMN NewsFeed - 17 Feb 2016
Interpace Diagnostics Receives Medicare Coverage For Its ThyraMIR(TM) Micro RNA Gene Expression Classifer
Interpace Diagnostics Receives Medicare Coverage For Its ThyraMIR(TM) Micro RNA Gene Expression Classifer
HSMN NewsFeed - 19 Jan 2016
Twist Bioscience Completes $61 Million Series D Financing And $20 Million Debt Facility
Twist Bioscience Completes $61 Million Series D Financing And $20 Million Debt Facility
HSMN NewsFeed - 12 Jan 2016
Interpace Diagnostics' New Molecular Test for Thyroid Nodules Now Available Through LabCorp
Interpace Diagnostics' New Molecular Test for Thyroid Nodules Now Available Through LabCorp
HSMN NewsFeed - 12 Nov 2015
Rosetta Provides Update on Performance Data and Launch of RosettaGX Reveal(TM) (Thyroid microRNA Classifier)
Rosetta Provides Update on Performance Data and Launch of RosettaGX Reveal(TM) (Thyroid microRNA Classifier)
HSMN NewsFeed - 27 Oct 2015
Transgenomic Launches New Genetic Testing Service for Diagnosis of Charcot-Marie-Tooth Syndrome
Transgenomic Launches New Genetic Testing Service for Diagnosis of Charcot-Marie-Tooth Syndrome
HSMN NewsFeed - 21 Oct 2015
Unum Therapeutics Expands Leadership Team by Appointing Dr. Michael J. Vasconcelles as Chief Medical Officer
Unum Therapeutics Expands Leadership Team by Appointing Dr. Michael J. Vasconcelles as Chief Medical Officer
HSMN NewsFeed - 15 Oct 2015
GenomeDx Biosciences Adds Tina Nova and Craig Johnson to Board of Directors
GenomeDx Biosciences Adds Tina Nova and Craig Johnson to Board of Directors
HSMN NewsFeed - 7 Oct 2015
Luminex Corporation Receives FDA Clearance for ARIES(R) System and ARIES(R) HSV 1&2 Assay
Luminex Corporation Receives FDA Clearance for ARIES(R) System and ARIES(R) HSV 1&2 Assay
HSMN NewsFeed - 21 Jul 2015
Technology Industry Veteran Phil Mui Joins HeartFlow Product & Engineering Team
Technology Industry Veteran Phil Mui Joins HeartFlow Product & Engineering Team
HSMN NewsFeed - 14 Jul 2015
Biocept Launches Diagnostic Assay for BRAF Mutations in Patients with Melanoma
Biocept Launches Diagnostic Assay for BRAF Mutations in Patients with Melanoma
HSMN NewsFeed - 14 Jul 2015
Transgenomic Launches Most Comprehensive Genetic Test for Diagnosis of Leukodystrophy
Transgenomic Launches Most Comprehensive Genetic Test for Diagnosis of Leukodystrophy
HSMN NewsFeed - 9 Jun 2015
Opexa Hires Experienced Pharmaceutical Executive as Vice President of Business Development
Opexa Hires Experienced Pharmaceutical Executive as Vice President of Business Development
HSMN NewsFeed - 30 Jul 2014
Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
HSMN NewsFeed - 7 Jul 2014
Provista Diagnostics, Inc. Appoints Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer
Provista Diagnostics, Inc. Appoints Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer
HSMN NewsFeed - 8 Apr 2014
Epic Sciences Appoints Pascal Bamford, Ph.D. as Vice President of Product Development
Epic Sciences Appoints Pascal Bamford, Ph.D. as Vice President of Product Development
HSMN NewsFeed - 18 Feb 2014
Rosetta Genomics Appoints Kevin Watson as Director, Reimbursement-Managed Care
Rosetta Genomics Appoints Kevin Watson as Director, Reimbursement-Managed Care
HSMN NewsFeed - 22 Jan 2014
LipoScience Announces Appointment of Howard Doran as President and Chief Executive Officer
LipoScience Announces Appointment of Howard Doran as President and Chief Executive Officer
HSMN NewsFeed - 13 Jan 2014
Arno Therapeutics Expands Management Team With Additions of Two Scientific Leaders
Arno Therapeutics Expands Management Team With Additions of Two Scientific Leaders
HSMN NewsFeed - 18 Dec 2013
Lineagen Announces $3.5 Million Series C Round and Close of Series B Financing
Lineagen Announces $3.5 Million Series C Round and Close of Series B Financing
HSMN NewsFeed - 5 Dec 2013
Cerner and Claritas Genomics Will Collaborate to Advance Personalized Medicine
Cerner and Claritas Genomics Will Collaborate to Advance Personalized Medicine
HSMN NewsFeed - 19 Nov 2013
Applied Proteomics Appoints Premal S. Shah As Vice President Of Business Development
Applied Proteomics Appoints Premal S. Shah As Vice President Of Business Development
HSMN NewsFeed - 8 Oct 2013
MolecularHealth Continues to Grow Management Team with New Chief Commercial Officer
MolecularHealth Continues to Grow Management Team with New Chief Commercial Officer
HSMN NewsFeed - 1 Oct 2013
BioMarker Strategies Names Jerry Parrott President and Chief Executive Officer
BioMarker Strategies Names Jerry Parrott President and Chief Executive Officer
HSMN NewsFeed - 6 Sep 2013
LipoScience Announces Appointment Of William Cromwell, M.D., As Chief Medical Officer
LipoScience Announces Appointment Of William Cromwell, M.D., As Chief Medical Officer
HSMN NewsFeed - 23 Aug 2013
Zimmer Receives FDA Clearance For Patient Specific Instruments (PSI) Shoulder
Zimmer Receives FDA Clearance For Patient Specific Instruments (PSI) Shoulder
HSMN NewsFeed - 2 Aug 2013
LipoScience Appoints Robert Greczyn Interim President and Chief Executive Officer
LipoScience Appoints Robert Greczyn Interim President and Chief Executive Officer
HSMN NewsFeed - 17 Jun 2013
Siemens to Create Companion Diagnostic Test for In-Development Janssen Heart Failure Drug
Siemens to Create Companion Diagnostic Test for In-Development Janssen Heart Failure Drug
HSMN NewsFeed - 22 May 2013
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 25 Jan 2013
Advanced Cell Diagnostics Appoints Evangeline Gonzalez as Chief Commercial Officer
Advanced Cell Diagnostics Appoints Evangeline Gonzalez as Chief Commercial Officer
HSMN NewsFeed - 16 Nov 2012
Saladax Biomedical, Inc. Appoints Mark D. Myslinski as Chief Commercial Officer
Saladax Biomedical, Inc. Appoints Mark D. Myslinski as Chief Commercial Officer
HSMN NewsFeed - 13 Nov 2012
Epic Sciences Announces Series B Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
Epic Sciences Announces Series B Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
HSMN NewsFeed - 11 Oct 2012
Rosetta Genomics Expands Management Team With Chief Medical Officer and Chief Scientific Officer
Rosetta Genomics Expands Management Team With Chief Medical Officer and Chief Scientific Officer
HSMN NewsFeed - 20 Sep 2012
Third Rock Ventures Launches MyoKardia with $38 Million to Address Genetic Heart Disease
Third Rock Ventures Launches MyoKardia with $38 Million to Address Genetic Heart Disease
HSMN NewsFeed - 13 Sep 2012
Transgenomic Announces Appointment of Mark P. Colonnese as Chief Financial Officer
Transgenomic Announces Appointment of Mark P. Colonnese as Chief Financial Officer
HSMN NewsFeed - 31 Jul 2012
Prometheus Launches New Monitoring Test To Help Guide Inflammatory Bowel Disease Management
Prometheus Launches New Monitoring Test To Help Guide Inflammatory Bowel Disease Management
HSMN NewsFeed - 30 Jul 2012
Biovest Advances Process Seeking European Marketing Approval for BiovaxID(TM) Personalized Lymphoma Vaccine
Biovest Advances Process Seeking European Marketing Approval for BiovaxID(TM) Personalized Lymphoma Vaccine
HSMN NewsFeed - 26 Jul 2012
Endocyte Appoints David Meek to Newly Created Position of Chief Commercial Officer
Endocyte Appoints David Meek to Newly Created Position of Chief Commercial Officer
HSMN NewsFeed - 25 Jul 2012
bioTheranostics Adds Chief Commercial Officer & VP of Corporate Development
bioTheranostics Adds Chief Commercial Officer & VP of Corporate Development
HSMN NewsFeed - 24 Jul 2012
Transgenomic Announces Medicare Coverage for Clopidogrel (Plavix(R)) Response Test
Transgenomic Announces Medicare Coverage for Clopidogrel (Plavix(R)) Response Test
HSMN NewsFeed - 18 Jul 2012
NeoGenomics Significantly Expands Molecular Testing Menu and Launches NeoTYPE(TM) Cancer Profile Panels
NeoGenomics Significantly Expands Molecular Testing Menu and Launches NeoTYPE(TM) Cancer Profile Panels
HSMN NewsFeed - 17 Jul 2012
Biodesix Appoints Vice President of Clinical Development & Medical Affairs
Biodesix Appoints Vice President of Clinical Development & Medical Affairs
HSMN NewsFeed - 9 Jul 2012
Agendia Names Industry Veteran Glen Fredenberg CFO and Vice President of Finance
Agendia Names Industry Veteran Glen Fredenberg CFO and Vice President of Finance
HSMN NewsFeed - 18 Jun 2012
Debiopharm and Ascepion Pharmaceuticals, Inc. Announce Exclusive License Agreement
Debiopharm and Ascepion Pharmaceuticals, Inc. Announce Exclusive License Agreement
HSMN NewsFeed - 15 Jun 2012
Saladax Biomedical, Inc. Appoints Kevin M. Harter as President and Chief Executive Officer
Saladax Biomedical, Inc. Appoints Kevin M. Harter as President and Chief Executive Officer
HSMN NewsFeed - 14 Jun 2012
GenMark Diagnostics Appoints Stephen T. Worland, Ph.D. to Board of Directors
GenMark Diagnostics Appoints Stephen T. Worland, Ph.D. to Board of Directors
HSMN NewsFeed - 1 Jun 2012
Agendia Announces Launch of ColoPrint for Colon Cancer Prognosis and Prediction
Agendia Announces Launch of ColoPrint for Colon Cancer Prognosis and Prediction
HSMN NewsFeed - 16 May 2012
Epizyme Announces Appointment of Eric Hedrick, M.D., as Chief Medical Officer
Epizyme Announces Appointment of Eric Hedrick, M.D., as Chief Medical Officer
HSMN NewsFeed - 16 May 2012
Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012
Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012
HSMN NewsFeed - 17 Apr 2012
Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer
Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer
HSMN NewsFeed - 28 Mar 2012
Kapil Dhingra, Former Head of Roche Oncology, Joins Exosome Diagnostics Board of Directors
Kapil Dhingra, Former Head of Roche Oncology, Joins Exosome Diagnostics Board of Directors
HSMN NewsFeed - 6 Mar 2012
Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy
Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy
HSMN NewsFeed - 27 Jan 2012
Roche commences tender offer for Illumina, Inc. for $44.50 per share in cash
Roche commences tender offer for Illumina, Inc. for $44.50 per share in cash
HSMN NewsFeed - 24 Jan 2012
Precision Therapeutics Enhances Their Straightforward Approach to Personalizing Cancer Care
Precision Therapeutics Enhances Their Straightforward Approach to Personalizing Cancer Care
HSMN NewsFeed - 6 Dec 2011
Agendia Introduces the SYMPHONY(TM) Breast Cancer Profile With Paraffin Embedded Tissue
Agendia Introduces the SYMPHONY(TM) Breast Cancer Profile With Paraffin Embedded Tissue
HSMN NewsFeed - 6 Dec 2011
Atossa Genetics Launches ForeCYTE Breast Health Test(SM) for Breast Cancer Risk Assessment
Atossa Genetics Launches ForeCYTE Breast Health Test(SM) for Breast Cancer Risk Assessment
HSMN NewsFeed - 29 Nov 2011
Philips Receives FDA Clearance to Market Its First Whole Body PET/MR Imaging System in the United States
Philips Receives FDA Clearance to Market Its First Whole Body PET/MR Imaging System in the United States
HSMN NewsFeed - 7 Sep 2011
TrovaGene, Inc., Announces Worldwide Exclusive Licensing of Assay for Hairy Cell Leukemia
TrovaGene, Inc., Announces Worldwide Exclusive Licensing of Assay for Hairy Cell Leukemia
HSMN NewsFeed - 27 Aug 2011
Abbott Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection
Abbott Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection
HSMN NewsFeed - 1 Aug 2011
Roche Appoints Mara G. Aspinall President of Ventana Medical Systems, Inc.
Roche Appoints Mara G. Aspinall President of Ventana Medical Systems, Inc.
HSMN NewsFeed - 19 Jul 2011
Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing
Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing
HSMN NewsFeed - 3 Jun 2011
Breast Cancer Genomic Test Shown to Predict Patient Survival Following Adjuvant Chemotherapy
Breast Cancer Genomic Test Shown to Predict Patient Survival Following Adjuvant Chemotherapy
HSMN NewsFeed - 1 Jun 2011
ConforMIS Receives CE Mark Certification for iTotal(R) CR Patient-Specific Total Knee Resurfacing System
ConforMIS Receives CE Mark Certification for iTotal(R) CR Patient-Specific Total Knee Resurfacing System
HSMN NewsFeed - 24 May 2011
Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
HSMN NewsFeed - 19 May 2011
Vermillion Announces the Appointment of Bruce Huebner to its Board of Directors
Vermillion Announces the Appointment of Bruce Huebner to its Board of Directors
HSMN NewsFeed - 18 May 2011
Molecular Response Appoints Kenna Anderes, PhD, as Senior Vice President of Translational Medicine
Molecular Response Appoints Kenna Anderes, PhD, as Senior Vice President of Translational Medicine
HSMN NewsFeed - 19 Apr 2011
STAR Orthopaedics to Host Clinical Trial of FDA Approved Personalized Knee Implant
STAR Orthopaedics to Host Clinical Trial of FDA Approved Personalized Knee Implant
HSMN NewsFeed - 6 Apr 2011
GenMark Diagnostics Appoints Hany Massarany President and Chief Executive Officer
GenMark Diagnostics Appoints Hany Massarany President and Chief Executive Officer
HSMN NewsFeed - 4 Apr 2011
Tobira Therapeutics Appoints Andrew Hindman President and Chief Executive Officer
Tobira Therapeutics Appoints Andrew Hindman President and Chief Executive Officer
HSMN NewsFeed - 21 Mar 2011
Selventa Names John Tagliamonte as Senior Vice President of Corporate Development
Selventa Names John Tagliamonte as Senior Vice President of Corporate Development
HSMN NewsFeed - 3 Mar 2011
BoneGrafix Moves Forward with Development of Next Generation Bone Repair Products
BoneGrafix Moves Forward with Development of Next Generation Bone Repair Products
HSMN NewsFeed - 3 Feb 2011
FDA Clears First Patient-Specific Implant System for Total Knee Replacement
FDA Clears First Patient-Specific Implant System for Total Knee Replacement
HSMN NewsFeed - 27 Jan 2011
H3 Biomedicine Launches to Discover and Develop Next Generation Cancer Treatments
H3 Biomedicine Launches to Discover and Develop Next Generation Cancer Treatments
HSMN NewsFeed - 19 Jan 2011
Genentech Personalized Investigational Medicine Shows Survival Benefit in Advanced Skin Cancer
Genentech Personalized Investigational Medicine Shows Survival Benefit in Advanced Skin Cancer
HSMN NewsFeed - 17 Jan 2011
AdvanDx Receives FDA 510(k) Clearance for GNR Traffic Light(TM) PNA FISH(R)
AdvanDx Receives FDA 510(k) Clearance for GNR Traffic Light(TM) PNA FISH(R)
HSMN NewsFeed - 6 Jan 2011
Corgenix Announces 28 Percent Increase in Reimbursement Rate for AspirinWorks(R) Test
Corgenix Announces 28 Percent Increase in Reimbursement Rate for AspirinWorks(R) Test
HSMN NewsFeed - 20 Dec 2010
Myriad Genetics Launches PANEXIA, New Predictive Test for Hereditary Pancreatic and Related Cancers
Myriad Genetics Launches PANEXIA, New Predictive Test for Hereditary Pancreatic and Related Cancers
HSMN NewsFeed - 19 Nov 2010
VeriStrat(R) Test Identifies Lung Cancer Patients Benefiting from Combination Therapy
VeriStrat(R) Test Identifies Lung Cancer Patients Benefiting from Combination Therapy
HSMN NewsFeed - 13 Oct 2010
BioScale Appoints Peter H. Lewis as Vice President of Finance and Administration
BioScale Appoints Peter H. Lewis as Vice President of Finance and Administration
HSMN NewsFeed - 5 Oct 2010
Mayo Researchers Find Biomarkers for Personalizing Radiation Cancer Treatment
Mayo Researchers Find Biomarkers for Personalizing Radiation Cancer Treatment
HSMN NewsFeed - 23 Sep 2010
BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
HSMN NewsFeed - 20 Sep 2010
Molecular Response Announced Today the Appointment of Cyrus K. Mirsaidi to Chief Executive Officer
Molecular Response Announced Today the Appointment of Cyrus K. Mirsaidi to Chief Executive Officer
HSMN NewsFeed - 12 Aug 2010
Radient Pharmaceuticals Appoints Gary Giarratano as Director of North American Sales and Marketing
Radient Pharmaceuticals Appoints Gary Giarratano as Director of North American Sales and Marketing
HSMN NewsFeed - 3 Jun 2010
EPEMED, the European Personalised Medicine Association, Appoints Executive Director
EPEMED, the European Personalised Medicine Association, Appoints Executive Director
HSMN NewsFeed - 19 May 2010
Caris Life Sciences Names Jonathan Knowles, Ph.D., Chief Scientific Officer
Caris Life Sciences Names Jonathan Knowles, Ph.D., Chief Scientific Officer
HSMN NewsFeed - 10 May 2010
AltheaDx Announces Appointment of New CEO and President and Adds Dr. Ann Kessler to the Board of Directors
AltheaDx Announces Appointment of New CEO and President and Adds Dr. Ann Kessler to the Board of Directors
HSMN NewsFeed - 23 Apr 2010
Genentech Submits Supplemental Application to FDA for Herceptin in Advanced HER2-Positive Stomach Cancer
Genentech Submits Supplemental Application to FDA for Herceptin in Advanced HER2-Positive Stomach Cancer
HSMN NewsFeed - 15 Apr 2010
CE Certification Granted for IBA's 2nd Generation Pencil Beam Scanning Proton Treatment System
CE Certification Granted for IBA's 2nd Generation Pencil Beam Scanning Proton Treatment System
HSMN NewsFeed - 17 Mar 2010
New Data Indicate Effectiveness of Clarient's Ovotax(TM) Test for Ovarian Cancer
New Data Indicate Effectiveness of Clarient's Ovotax(TM) Test for Ovarian Cancer
HSMN NewsFeed - 2 Mar 2010
Myriad Genetics Launches PROLARIS(TM): First Diagnostic Test to Predict Prostate Cancer Recurrence
Myriad Genetics Launches PROLARIS(TM): First Diagnostic Test to Predict Prostate Cancer Recurrence
HSMN NewsFeed - 24 Feb 2010
Appeal of Lawsuit by Former Officer Dismissed; Request for Sanctions Granted
Appeal of Lawsuit by Former Officer Dismissed; Request for Sanctions Granted
HSMN NewsFeed - 26 Jan 2010
Prometheus Acquires Exclusive Rights to PROLEUKIN(R) (aldesleukin) in the U.S.
Prometheus Acquires Exclusive Rights to PROLEUKIN(R) (aldesleukin) in the U.S.
HSMN NewsFeed - 20 Jan 2010
Medco to Advance Cancer Care with Personalized and Specialized Treatment for Oncology Patients
Medco to Advance Cancer Care with Personalized and Specialized Treatment for Oncology Patients
HSMN NewsFeed - 18 Jan 2010
AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments
AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments
HSMN NewsFeed - 18 Jan 2010
Med BioGene Appoints World-Renowned Geneticist Dr. Michael R. Hayden as Director
Med BioGene Appoints World-Renowned Geneticist Dr. Michael R. Hayden as Director
HSMN NewsFeed - 13 Jan 2010
Population Diagnostics, Inc. Appoints Dr. Peggy Eis as Chief Technology Officer
Population Diagnostics, Inc. Appoints Dr. Peggy Eis as Chief Technology Officer
HSMN NewsFeed - 16 Dec 2009
Caris Diagnostics Names New Vice Chairman and Board Member, Dr. Jonathan Knowles
Caris Diagnostics Names New Vice Chairman and Board Member, Dr. Jonathan Knowles
HSMN NewsFeed - 28 Oct 2009
MolecularMD Establishes New Operations Facility to Support Growth in Personalized Cancer Medicine Business
MolecularMD Establishes New Operations Facility to Support Growth in Personalized Cancer Medicine Business
HSMN NewsFeed - 15 Sep 2009
Caris Diagnostics Appoints Thomas T. Spalding to Senior Vice President, Chief Marketing Officer
Caris Diagnostics Appoints Thomas T. Spalding to Senior Vice President, Chief Marketing Officer
HSMN NewsFeed - 10 Sep 2009
Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement
Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement
HSMN NewsFeed - 24 Aug 2009
Aperio Receives Second FDA Clearance for HER2 Image Analysis Application for Breast Cancer
Aperio Receives Second FDA Clearance for HER2 Image Analysis Application for Breast Cancer
HSMN NewsFeed - 20 Aug 2009
VistaGen Appoints Industry Veteran Shawn Singh as Chief Executive Officer
VistaGen Appoints Industry Veteran Shawn Singh as Chief Executive Officer
HSMN NewsFeed - 21 Jul 2009
C-RAD Sentinel(TM) selected as Elekta preferred solution for Intra Fraction Motion Detection
C-RAD Sentinel(TM) selected as Elekta preferred solution for Intra Fraction Motion Detection
HSMN NewsFeed - 20 Jul 2009
ChemGenex Appoints Mr. Thomas DeZao as Senior Vice President and Chief Commercial Officer
ChemGenex Appoints Mr. Thomas DeZao as Senior Vice President and Chief Commercial Officer
HSMN NewsFeed - 5 May 2009
Biodesix Advances the Field of Personalized Medicine With the Launch of VeriStrat(R)
Biodesix Advances the Field of Personalized Medicine With the Launch of VeriStrat(R)
HSMN NewsFeed - 20 Apr 2009
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)
HSMN NewsFeed - 18 Mar 2009
Power3 Medical 'On-Track and On-Plan' to Commercialize Diagnostic Blood Tests
Power3 Medical 'On-Track and On-Plan' to Commercialize Diagnostic Blood Tests
HSMN NewsFeed - 25 Feb 2009
ARCA biopharma Appoints Kathryn Falberg as Chief Financial Officer and Chief Operating Officer
ARCA biopharma Appoints Kathryn Falberg as Chief Financial Officer and Chief Operating Officer
HSMN NewsFeed - 18 Feb 2009
Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer
Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer
HSMN NewsFeed - 4 Feb 2009
Agendia's Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
Agendia's Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
HSMN NewsFeed - 3 Feb 2009
Warnex Offers New Personalized Medicine Service: K-ras Mutation Analysis for Colorectal Cancer
Warnex Offers New Personalized Medicine Service: K-ras Mutation Analysis for Colorectal Cancer
HSMN NewsFeed - 19 Jan 2009
IBT Labs Adds Senior R&D, Marketing, and Sales Executives to Leadership Team
IBT Labs Adds Senior R&D, Marketing, and Sales Executives to Leadership Team
HSMN NewsFeed - 22 Dec 2008
Myriad Genetics Launches Sixth Personalized Medicine Product, Prezeon -- to Reveal PTEN Status
Myriad Genetics Launches Sixth Personalized Medicine Product, Prezeon -- to Reveal PTEN Status
HSMN NewsFeed - 15 Dec 2008
Rcadia Medical Imaging Closes $3.3 Million Investment Led by BioVentures Investors
Rcadia Medical Imaging Closes $3.3 Million Investment Led by BioVentures Investors
HSMN NewsFeed - 12 Dec 2008
Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
HSMN NewsFeed - 2 Dec 2008
BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development
BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development
HSMN NewsFeed - 28 Oct 2008
Ikonisys Receives FDA Clearance for Non-Invasive, HER-2 Breast Cancer Test
Ikonisys Receives FDA Clearance for Non-Invasive, HER-2 Breast Cancer Test
HSMN NewsFeed - 23 Sep 2008
TheraGenetics Appoints Robert McBurney, Ph.D. as Executive Vice President
TheraGenetics Appoints Robert McBurney, Ph.D. as Executive Vice President
HSMN NewsFeed - 14 Aug 2008
ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
HSMN NewsFeed - 30 Jun 2008
Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe
Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe
HSMN NewsFeed - 5 May 2008
ParagonDx Receives FDA 510(k) Marketing Clearance for Warfarin Sensitivity Genotyping Kit
ParagonDx Receives FDA 510(k) Marketing Clearance for Warfarin Sensitivity Genotyping Kit
HSMN NewsFeed - 13 Mar 2008
Clinical Data, Inc. Initiates Second Pivotal Phase III Study of Vilazodone
Clinical Data, Inc. Initiates Second Pivotal Phase III Study of Vilazodone
HSMN NewsFeed - 7 Mar 2008
Abbott to Collaborate With Genentech, Roche and OSI on Molecular Test for Lung Cancer Therapy Response
Abbott to Collaborate With Genentech, Roche and OSI on Molecular Test for Lung Cancer Therapy Response
HSMN NewsFeed - 23 Jan 2008
Michael L. Salgaller, Ph.D., Appointed Chief Operating Officer of Calibrant Biosystems
Michael L. Salgaller, Ph.D., Appointed Chief Operating Officer of Calibrant Biosystems
HSMN NewsFeed - 10 Jan 2008
Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory
Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory
HSMN NewsFeed - 4 Dec 2007
Oracle Healthcare Acquisition Corp. and Precision Therapeutics Announce Definitive Merger Agreement
Oracle Healthcare Acquisition Corp. and Precision Therapeutics Announce Definitive Merger Agreement
HSMN NewsFeed - 6 Nov 2007
30-Year Johnson & Johnson Veteran Joins ConforMIS' Renowned Executive Team
30-Year Johnson & Johnson Veteran Joins ConforMIS' Renowned Executive Team
HSMN NewsFeed - 7 Sep 2007
RXi Pharmaceuticals Names Life Science Veteran Stephen J. DiPalma Chief Financial Officer
RXi Pharmaceuticals Names Life Science Veteran Stephen J. DiPalma Chief Financial Officer
HSMN NewsFeed - 29 Aug 2007
ParagonDx Prepares Molecular Diagnostics Expansion After Acquisition of Gentris Diagnostics, Inc.
ParagonDx Prepares Molecular Diagnostics Expansion After Acquisition of Gentris Diagnostics, Inc.
HSMN NewsFeed - 17 Aug 2007
Osmetech responds to U.S. Food and Drug Administration ('FDA') update labelling for warfarin
Osmetech responds to U.S. Food and Drug Administration ('FDA') update labelling for warfarin
HSMN NewsFeed - 11 Jul 2007
Ventana's Board Unanimously Rejects Roche's Unsolicited Tender Offer as Inadequate
Ventana's Board Unanimously Rejects Roche's Unsolicited Tender Offer as Inadequate
HSMN NewsFeed - 4 Jul 2007
Researchers Identify Genetic Mutation That May Alter Patients' Response to Cancer Therapeutics
Researchers Identify Genetic Mutation That May Alter Patients' Response to Cancer Therapeutics
HSMN NewsFeed - 7 Jun 2007
Biodesix, Inc. Announces Breakthrough In Molecular Diagnostics For Lung Cancer
Biodesix, Inc. Announces Breakthrough In Molecular Diagnostics For Lung Cancer
HSMN NewsFeed - 24 Apr 2007
Luminex Licenses Cystic Fibrosis Gene Patent From John Hopkins University
Luminex Licenses Cystic Fibrosis Gene Patent From John Hopkins University
HSMN NewsFeed - 17 Apr 2007
Millennium Discovers Biomarkers Potentially Predictive of Response to VELCADE(R) (Bortezomib) for Injection
Millennium Discovers Biomarkers Potentially Predictive of Response to VELCADE(R) (Bortezomib) for Injection
HSMN NewsFeed - 27 Mar 2007
Breakthrough Cancer Research at George Mason University Launches New Company
Breakthrough Cancer Research at George Mason University Launches New Company
HSMN NewsFeed - 8 Mar 2007
Clarient Sells Its ACIS(R) Instrument Business to Carl Zeiss for $12.5 Million
Clarient Sells Its ACIS(R) Instrument Business to Carl Zeiss for $12.5 Million
HSMN NewsFeed - 11 Dec 2006
Introgen Announces New Clinical Data Confirming ADVEXIN(R) Survival Benefit
Introgen Announces New Clinical Data Confirming ADVEXIN(R) Survival Benefit
HSMN NewsFeed - 6 Nov 2006
ARCA Discovery Names Richard B. Brewer President and Chief Executive Officer
ARCA Discovery Names Richard B. Brewer President and Chief Executive Officer
HSMN NewsFeed - 31 Oct 2006
Gene Expression Test From XDx Now Indicated for Earlier Use and Prediction of Acute Cellular Rejection
Gene Expression Test From XDx Now Indicated for Earlier Use and Prediction of Acute Cellular Rejection
HSMN NewsFeed - 30 Oct 2006
ARCA Discovery, Inc. Names Thomas Keuer Executive Vice President of Pharmaceutical Operations
ARCA Discovery, Inc. Names Thomas Keuer Executive Vice President of Pharmaceutical Operations
HSMN NewsFeed - 4 Oct 2006
Plexxikon and Roche Enter Partnership to Develop Targeted Cancer Therapeutic Medicine PLX4032
Plexxikon and Roche Enter Partnership to Develop Targeted Cancer Therapeutic Medicine PLX4032
HSMN NewsFeed - 18 Jul 2006
HistoRx Names John Tonkinson, Ph.D., Vice President, Business Development
HistoRx Names John Tonkinson, Ph.D., Vice President, Business Development
HSMN NewsFeed - 1 Jun 2006
Cell Therapeutics, Inc. (CTI) and FDA Agree on NDA Filing Strategy for XYOTAX(TM)
Cell Therapeutics, Inc. (CTI) and FDA Agree on NDA Filing Strategy for XYOTAX(TM)
Additional items found! 72

Members Archive contains
72 additional stories matching:
Personalized Medicine
(Password required)
Personalized Medicine
(Password required)